Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
iShares Global Consumer Staples ETF
KXI
$1.07B
| $301K | ﹤0.01% |
5,200
| – | – |
|
3077
Alignment Healthcare
ALHC
$2.78B
| $299K | ﹤0.01% |
26,218
-5,745
| -18% | -$60.6K |
|
3078
AtriCure
ATRC
$2.01B
| $299K | ﹤0.01% |
7,339
-3,359
| -31% | -$159K |
|
3079
Greenlight Captial
GLRE
$511M
| $298K | ﹤0.01% |
38,578
-2,957
| -7% | -$21.7K |
|
|
AAMI
3080
Acadian Asset Management
AAMI
$3.26B
| $298K | ﹤0.01% |
16,535
-16,253
| -50% | -$333K |
|
3081
Karooooo
KARO
$1.97B
| $296K | ﹤0.01% |
13,786
+2,719
| +25% | +$73.6K |
|
|
TGI
3082
DELISTED
Triumph Group
TGI
| $296K | ﹤0.01% |
22,305
-29,310
| -57% | -$555K |
|
3083
Curis
CRIS
$8.59M
| $295K | ﹤0.01% |
750
-36
| -5% | -$15K |
|
|
PETQ
3084
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $295K | ﹤0.01% |
17,564
-3,107
| -15% | -$57K |
|
3085
CVR Energy
CVI
$3.15B
| $294K | ﹤0.01% |
8,736
+3,744
| +75% | +$120K |
|
3086
Equinor
EQNR
$93.7B
| $294K | ﹤0.01% |
8,449
-6,817
| -45% | -$244K |
|
3087
Vital Farms
VITL
$536M
| $294K | ﹤0.01% |
33,620
-2,664
| -7% | -$28.4K |
|
|
KLRS
3088
Kalaris Therapeutics
KLRS
$99.7M
| $294K | ﹤0.01% |
3,279
+2,435
| +289% | +$255K |
|
3089
Ingevity
NGVT
$2.66B
| $293K | ﹤0.01% |
4,657
-5,656
| -55% | -$369K |
|
3090
Unitil
UTL
$981M
| $293K | ﹤0.01% |
4,986
-7,735
| -61% | -$418K |
|
|
CDMO
3091
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $293K | ﹤0.01% |
19,193
-30,264
| -61% | -$448K |
|
3092
Rush Street Interactive
RSI
$2.9B
| $292K | ﹤0.01% |
62,400
-5,733
| -8% | -$34.1K |
|
|
MBT
3093
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $292K | ﹤0.01% |
252,973
| – | – |
|
|
ENV
3094
DELISTED
ENVESTNET, INC.
ENV
| $292K | ﹤0.01% |
5,520
-106,613
| -95% | -$7.29M |
|
3095
Coeur Mining
CDE
$16.1B
| $291K | ﹤0.01% |
95,433
-238,277
| -71% | -$936K |
|
3096
First Bancorp
FNLC
$398M
| $291K | ﹤0.01% |
9,658
-1,193
| -11% | -$34.9K |
|
|
GGAA
3097
DELISTED
Genesis Growth Tech Acquisition Corp. Class A Ordinary Shares
GGAA
| $291K | ﹤0.01% |
28,984
| – | – |
|
3098
Haemonetics
HAE
$3.86B
| $289K | ﹤0.01% |
4,436
-7,822
| -64% | -$463K |
|
3099
Microvast
MVST
$261M
| $289K | ﹤0.01% |
130,229
+69,134
| +113% | +$297K |
|
3100
James River Group Holdings
JRVR
$221M
| $288K | ﹤0.01% |
11,627
-18,091
| -61% | -$443K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.